Innovations in reprogramming cells, compounds for activating killer T cells, polypeptides to modulate insulin receptors, analyte detection kits, slippery surfaces, and more

Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease

Synthetic biology-based diagnostic platform enables low-cost, highly sensitive detection of nucleic acids in a wide range of settings

Venture capitalists, executives and legal experts are a phone call away for innovative Harvard researchers